Lunit
Conquering cancer together through the power of AI
Seoul, South Korea · Founded 2013
About
Lunit is a Seoul-based medical AI company founded in 2013 that develops AI-powered software for cancer screening and precision oncology. Its flagship products — Lunit INSIGHT MMG, CXR, and DBT — are FDA-cleared and CE-marked tools used by over 10,000 medical institutions worldwide to detect breast cancer and lung nodules in imaging studies. Lunit's SCOPE platform provides AI biomarker analysis (PD-L1, HER2, IO) for biopharma R&D and clinical pathology, with partnerships including AstraZeneca, Microsoft, GE Healthcare, and Philips. The company completed its IPO on KOSDAQ in 2022 and acquired Volpara Health in 2024 to expand its breast health AI ecosystem.
Summary
Lunit is an Artificial Intelligence company based in Seoul, South Korea, founded in 2013.
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...